Dozens of telehealth companies have recently launched to prescribe novel weight loss drugs. Their practices are raising concern among doctors. Sponsored by Patients seeking novel weight loss drugs find a 'wild west' of online prescribers By Katie Palmer Alex Hogan/STAT Dozens of telehealth companies have recently launched to prescribe novel weight loss drugs. Their practices are raising concern among doctors. Read More U.S. declares monkeypox outbreak a public health emergency By Helen Branswell NIAID The declaration gives the administration more flexibility and powers with which to try to halt spread of the virus. Read More Covid has settled into a persistent pattern — and remains damaging. It may not change anytime soon By Andrew Joseph Mario Tama/Getty Images In some ways, Covid increasingly looks like other respiratory infections — mild in many people, but sometimes severe in high-risk populations. Read More Sponsor content by STAT Events Biomarkers: The Foundation of Personalized Oncology Register for a virtual event on August 17 to hear researchers, academics, and business leaders discuss what recent innovations in biomarkers mean for the future of cancer treatments. STAT+: Amgen to acquire ChemoCentryx for $4 billion, adding newly approved drug for autoimmune disorder By Adam Feuerstein Mark J. Terrill/AP The centerpiece of Amgen’s acquisition is a pill called Tavneos that treats patients with ANCA-associated vasculitis, an autoimmune disease Read More With monkeypox vaccine in high demand, NIH to test approaches to stretch supplies By Helen Branswell Jessica Christian/San Francisco Chronicle via AP The global need for monkeypox vaccine outstrips the supply, and will likely continue to do so for quite some time. Read More New research digs into the genetic drivers of heart failure, with an eye to precision treatments By Elizabeth Cooney Adobe The study raises the possibility that some of the molecular pathways that lead to heart failure could be precisely targeted. Read More Opinion: Addressing social drivers of health is a big opportunity for tech entrepreneurs By Ken Frazier Sue Ogrocki/AP Addressing social drivers of health is often left to government programs and policies. Innovative new companies can do it faster and better. Read More Listen: The last-minute push for drug pricing reform, Alnylam's success, and Sarepta's gamble By Damian Garde and Allison DeAngelis and Adam Feuerstein Rachel Cohrs, STAT's Washington correspondent, joins us to explain how congressional Democrats are on the verge of a coup in drug pricing. Read More Opinion: The outsized effect of 'modest' price controls on pharmaceutical innovation By Standish Fleming Adobe Industry advocates must explain how taking excess profits from pharma giants will affect startups, the real engine of pharma innovation. Read More Thursday, August 4, 2022 1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser
No comments